TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 17415320

Group type: EXPERIMENTAL
Intervention: High-protein, low-fat diet (HPLF)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: High-carbohydrate, low-fat diet (HCLF)
Number of subjects: 20
Study: 15247339

Group type: EXPERIMENTAL
Intervention: Intrapartum nevirapine
Number of subjects: 1844

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1844
Study: 11782035

Group type: EXPERIMENTAL
Intervention: Stratification on the rank of the event
Number of subjects: 1265

Group type: EXPERIMENTAL
Intervention: Non-stratified approach related to Poisson processes theory
Number of subjects: 1265
Study: 9264578

Group type: EXPERIMENTAL
Intervention: Intraperitoneal FUDR + cisplatin (60 mg/m2 in 500 mL of NS)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Intraperitoneal FUDR + carboplatin (AUC of 5)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Intraperitoneal FUDR + cisplatin (or both platinums)
Number of subjects: 18
Study: 8495682

Group type: EXPERIMENTAL
Intervention: Oral omeprazole 40 mg the evening before surgery
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Oral omeprazole 40 mg 2 h before surgery
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Effervescent cimetidine 800 mg, 2 h before surgery
Number of subjects: 60

Group type: COMPARATOR
Intervention: No antacid (control group)
Number of subjects: 60
Study: 3076118

Group type: EXPERIMENTAL
Intervention: Gemfibrozil 600mg twice daily
Number of subjects: 4081

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4081
Study: 29194488

Group type: EXPERIMENTAL
Intervention: Isavuconazole
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: Voriconazole
Number of subjects: 142
Study: 28396179

Group type: EXPERIMENTAL
Intervention: Dance group (60 minutes weekly for 40 weeks)
Number of subjects: 201

Group type: EXPERIMENTAL
Intervention: Music group (60 minutes weekly for 40 weeks)
Number of subjects: 201

Group type: COMPARATOR
Intervention: Health education control group
Number of subjects: 201
Study: 26568937

Group type: EXPERIMENTAL
Intervention: Oral gabapentin 20 mg/kg
Number of subjects: 3

Group type: COMPARATOR
Intervention: Local bupivacaine 2.5 ml 0.25%
Number of subjects: 3

Group type: COMPARATOR
Intervention: Intravenous pethidine 1 mg/kg
Number of subjects: 3
Study: 24041982

Group type: EXPERIMENTAL
Intervention: Training on interpreting fundus photographs
Number of subjects: 138

Group type: COMPARATOR
Intervention: Direct ophthalmoscopy on simulators
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Fundus photographs
Number of subjects: 138

Group type: COMPARATOR
Intervention: Direct ophthalmoscopy on simulators or humans
Number of subjects: 138
Study: 21150717

Group type: EXPERIMENTAL
Intervention: WT1 peptide vaccine and gemcitabine (GEM) combination therapy
Number of subjects: 25
Study: 18434914

Group type: EXPERIMENTAL
Intervention: Protocol-directed sedation management (n = 153)
Number of subjects: 312

Group type: COMPARATOR
Intervention: Usual local clinical practice (control, n = 159)
Number of subjects: 312
Study: 16799184

Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma gel
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control (saline gel) dressing
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma gel (after adjusting for wound size outliers)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control (after adjusting for wound size outliers)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Time-to-healing
Number of subjects: 72
Study: 12457587

Group type: EXPERIMENTAL
Intervention: Bifidobacterium breve strain Yakult-fermented soymilk
Number of subjects: 0
Study: 11167236

Group type: EXPERIMENTAL
Intervention: Combination of bacitracin and neomycin
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Ofloxacin
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Tetracycline
Number of subjects: 47
Study: 8901773

Group type: EXPERIMENTAL
Intervention: rPF4 (1.0 mg/kg IV over 2 minutes)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Protamine (50 mg IV over 10 minutes)
Number of subjects: 81
Study: 1798376

Group type: EXPERIMENTAL
Intervention: Treadmill running
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Ergometer rowing
Number of subjects: 10

Group type: COMPARATOR
Intervention: Arm cranking
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Capillary blood lactate
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Arterial bicarbonate
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: pH levels
Number of subjects: 10
Study: 7045754

Group type: EXPERIMENTAL
Intervention: Cefoxitin (2-dose course)
Number of subjects: 91

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 91
Study: 31241541

Group type: EXPERIMENTAL
Intervention: Immediate ART
Number of subjects: 1134

Group type: COMPARATOR
Intervention: Deferred ART
Number of subjects: 1134
Study: 27636836

Group type: EXPERIMENTAL
Intervention: Segmental traction therapy along with conventional physiotherapy, 15 sessions, 5 times a week for 3 weeks.
Number of subjects: 15
Study: 25935214

Group type: EXPERIMENTAL
Intervention: Social network peer education intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control arm participants
Number of subjects: 0
Study: 23172404

Group type: EXPERIMENTAL
Intervention: High skilled hand (HS) to low skilled hand (LS) transfer
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Low skilled hand (LS) to high skilled hand (HS) transfer
Number of subjects: 80

Group type: COMPARATOR
Intervention: Residual pinch force
Number of subjects: 80

Group type: COMPARATOR
Intervention: Upper limb motricity (Motricity Index)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Side of hemiparesis
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Strategy adopted in the first trial
Number of subjects: 80
Study: 21878941

Group type: EXPERIMENTAL
Intervention: cediranib 20 mg per day plus carboplatin and paclitaxel
Number of subjects: 60

Group type: COMPARATOR
Intervention: placebo plus carboplatin and paclitaxel
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: cediranib 20 mg per day followed by cediranib (concurrent plus maintenance)
Number of subjects: 60
Study: 19643440

Group type: EXPERIMENTAL
Intervention: Oxandrolone (Ox)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo (Pl)
Number of subjects: 44
Study: 17847641

Group type: EXPERIMENTAL
Intervention: Calcium carbonate air polishing (Prophypearls)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Glycine air polishing (ClinPro Prophypowder)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control groups (no air polishing)
Number of subjects: 0
Study: 15455650

Group type: EXPERIMENTAL
Intervention: Mediterranean‐type diet (MD)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Red wine supplementation (240 ml/day) with MD
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Red wine supplementation (240 ml/day) with HFD
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Red wine supplementation
Number of subjects: 42

Group type: COMPARATOR
Intervention: High‐fat diet (HFD)
Number of subjects: 42
Study: 11432629

Group type: EXPERIMENTAL
Intervention: Neoadjuvant therapy (MMM chemotherapy for ER-negative patients: methotrexate 30 mg/m2, mitozantrone 7 mg/m2, mitomycin 7 mg/m2 every three weeks for three months; Goserelin 3.75 mg monthly for premenopausal ER-positive patients; Formestane 250 mg every two weeks for postmenopausal ER-positive patients)
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Neoadjuvant therapy
Number of subjects: 210
Study: 9800062

Group type: EXPERIMENTAL
Intervention: Naphcon‐A with lenses in place
Number of subjects: 23

Group type: COMPARATOR
Intervention: Naphcon‐A with lenses removed for 5 minutes
Number of subjects: 23
Study: 7829594

Group type: EXPERIMENTAL
Intervention: Laboratories' own procedures
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Consensus procedure established from best results of first panel
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Third panel with three positive samples and four successive dilutions
Number of subjects: 9
Study: 3139776

Group type: EXPERIMENTAL
Intervention: Aluminum hydroxide-adsorbed vaccine (25 micrograms protein and polysaccharide administered intramuscularly)
Number of subjects: 0

Group type: COMPARATOR
Intervention: 0.9% NaCl (control group for comparison)
Number of subjects: 0
Study: 30509509

Group type: EXPERIMENTAL
Intervention: Alirocumab 150 mg Q4W
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Alirocumab 150 mg Q2W
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 28240685

Group type: EXPERIMENTAL
Intervention: Men with primary hypertension
Number of subjects: 209

Group type: COMPARATOR
Intervention: Women with primary hypertension
Number of subjects: 209

Group type: EXPERIMENTAL
Intervention: Overall population
Number of subjects: 209

Group type: EXPERIMENTAL
Intervention: Low cardiorespiratory fitness (CRF) group
Number of subjects: 209
Study: 25928792

Group type: EXPERIMENTAL
Intervention: Audit and feedback intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Education (control)
Number of subjects: 0
Study: 23596980

Group type: EXPERIMENTAL
Intervention: Health-based intervention
Number of subjects: 477

Group type: EXPERIMENTAL
Intervention: Islamic-based intervention
Number of subjects: 477

Group type: EXPERIMENTAL
Intervention: Combined program
Number of subjects: 477

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 477
Study: 21192125

Group type: EXPERIMENTAL
Intervention: Naltrexone treatment (Depotrex; Biotek, Inc.)
Number of subjects: 34
Study: 19876678

Group type: EXPERIMENTAL
Intervention: 3-week 10-Hz high frequency rTMS add on to antipsychotic therapy, 15 sessions per 3 weeks, 1,000 stimuli per session, stimulation intensity 110% of the individual motor threshold
Number of subjects: 126

Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: 3-week 10-Hz high frequency rTMS add on to antipsychotic therapy
Number of subjects: 126
Study: 17023843

Group type: EXPERIMENTAL
Intervention: 3% volume of end-tidal sevoflurane concentration maintained for at least 10 minutes
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: End-tidal sevoflurane concentration tested at 1.0% to 0.1% volume with an interval of 0.05% volume
Number of subjects: 30
Study: 12689403

Group type: EXPERIMENTAL
Intervention: Automated irrigation/suction system
Number of subjects: 47

Group type: COMPARATOR
Intervention: Standard pressurized technique
Number of subjects: 47
Study: 10968301

Group type: EXPERIMENTAL
Intervention: Self-paced exercise
Number of subjects: 155

Group type: COMPARATOR
Intervention: Class-based exercise
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: Dropout (D0)
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: Dropout (D3)
Number of subjects: 155
Study: 8968172

Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 20

Group type: COMPARATOR
Intervention: Halothane
Number of subjects: 20
Study: 1635654

Group type: EXPERIMENTAL
Intervention: 40 mg of lidocaine (xylocaine spray)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control group (no lidocaine)
Number of subjects: 35
Study: 6366248

Group type: EXPERIMENTAL
Intervention: Magnesium-containing Collins' 2 solution
Number of subjects: 5

Group type: COMPARATOR
Intervention: Magnesium-free Euro-Collins' solution
Number of subjects: 5
Study: 31436186

Group type: EXPERIMENTAL
Intervention: 360-degree rotation of IOL after placement in the capsular bag
Number of subjects: 50

Group type: COMPARATOR
Intervention: No rotation of IOL (control group)
Number of subjects: 50
Study: 29246745

Group type: EXPERIMENTAL
Intervention: LSE liposomal gel
Number of subjects: 0
Study: 25753429

Group type: EXPERIMENTAL
Intervention: Intradiscal methylene blue injection
Number of subjects: 15
Study: 25550680

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (0.5 μg.kg(‐1))
Number of subjects: 140

Group type: COMPARATOR
Intervention: Midazolam (0.025 μg.kg(‐1))
Number of subjects: 140
Study: 22841252

Group type: EXPERIMENTAL
Intervention: Harmonic scalpel for transection of short hepatic veins
Number of subjects: 16

Group type: COMPARATOR
Intervention: Conventional ligation for transection of short hepatic veins
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Harmonic scalpel for transection of small hepatic veins (≤ 2 mm)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Total and per vessel procedure time
Number of subjects: 16
Study: 20529754

Group type: EXPERIMENTAL
Intervention: 1/MaxSens (robustness measure)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Center of pressure measures of postural sway
Number of subjects: 30

Group type: COMPARATOR
Intervention: Gain and phase margins
Number of subjects: 30
Study: 18507654

Group type: EXPERIMENTAL
Intervention: Domperidone 30 mg daily
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Domperidone 60 mg daily
Number of subjects: 6
Study: 16162759

Group type: EXPERIMENTAL
Intervention: Thoracic epidural anesthesia followed by postoperative epidural analgesia (TEA) with bupivacaine
Number of subjects: 50

Group type: COMPARATOR
Intervention: Conventional IV anesthesia (CON)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Both groups (TEA and CON)
Number of subjects: 50
Study: 14596960

Group type: EXPERIMENTAL
Intervention: Revised confidentiality agreement (conditional confidentiality)
Number of subjects: 444

Group type: COMPARATOR
Intervention: Original consent form and protocol (unconditional confidentiality)
Number of subjects: 444
Study: 9558183

Group type: EXPERIMENTAL
Intervention: NSAID treatment
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 8
Study: 8980009

Group type: EXPERIMENTAL
Intervention: CAG trinucleotide repeat expansion detected using the repeat expansion detection (RED) method
Number of subjects: 2

Group type: COMPARATOR
Intervention: Normal controls
Number of subjects: 2
Study: 2370924

Group type: EXPERIMENTAL
Intervention: High-osmolality contrast media
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Calcium channel blocker (nifedipine)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Low-osmolality contrast media
Number of subjects: 30
Study: 363104

Group type: EXPERIMENTAL
Intervention: N-n-propyl norapomorphine (NPA) with suboptimal doses of levodopa
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: N-n-propyl norapomorphine (NPA) with levodopa plus carbidopa (Sinemet)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: N-n-propyl norapomorphine (NPA)
Number of subjects: 12
Study: 30740632

Group type: EXPERIMENTAL
Intervention: Fecal diversion device (FDD)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Ileostomy (stoma)
Number of subjects: 54
Study: 28236309

Group type: EXPERIMENTAL
Intervention: Individual supervision of home-visiting professionals
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Clinical supervision
Number of subjects: 0
Study: 26147387

Group type: EXPERIMENTAL
Intervention: Prehypertension (preHTN)
Number of subjects: 7802
Study: 23683600

Group type: EXPERIMENTAL
Intervention: Combination of teriparatide (20 μg daily) and denosumab (60 mg every 6 months)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Teriparatide (20 μg daily)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Denosumab (60 mg every 6 months)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Combination of teriparatide and denosumab
Number of subjects: 100
Study: 22024489

Group type: EXPERIMENTAL
Intervention: Mediterranean-style low-glycemic-load diet for 12 weeks
Number of subjects: 25
Study: 18300863

Group type: EXPERIMENTAL
Intervention: Irbesartan
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 16284226

Group type: EXPERIMENTAL
Intervention: Pulmonary arterial hypertension patients
Number of subjects: 46
Study: 12672281

Group type: EXPERIMENTAL
Intervention: RMP-7 and carboplatin
Number of subjects: 122

Group type: COMPARATOR
Intervention: Placebo and carboplatin
Number of subjects: 122
Study: 11529325

Group type: EXPERIMENTAL
Intervention: Ice test applied on the eyelids for 2 minutes
Number of subjects: 40
Study: 9751675

Group type: EXPERIMENTAL
Intervention: CABG (Coronary Artery Bypass Grafting)
Number of subjects: 1829

Group type: EXPERIMENTAL
Intervention: PTCA (Percutaneous Transluminal Coronary Angioplasty)
Number of subjects: 1829

Group type: COMPARATOR
Intervention: CABG
Number of subjects: 1829

Group type: COMPARATOR
Intervention: PTCA
Number of subjects: 1829

Group type: EXPERIMENTAL
Intervention: CABG and PTCA
Number of subjects: 1829
Study: 8064552

Group type: EXPERIMENTAL
Intervention: Topical liposome system bearing local anaesthetic lignocaine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional topical application
Number of subjects: 0
Study: 3287894

Group type: EXPERIMENTAL
Intervention: Undereating (4.2 MJ [1000 kcal] for 4 d)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Overeating (12.6 MJ [3000 kcal] for 2 d)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control (Undereating)
Number of subjects: 12
Study: 8272252

Group type: EXPERIMENTAL
Intervention: Dialysers containing cuprammonium cellulose (G10‐3N and G120 M)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Dialysers containing cuprammonium cellulose
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: PAN copolymer‐ and PMMA‐containing dialysers (Filtral and T 150)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Dialysers containing cellulose acetate and polysulphone membranes (Duo‐Flux Artificial Kidney, CD 4000, and F 60)
Number of subjects: 7
Study: 118360

Group type: EXPERIMENTAL
Intervention: Acetyldigoxin (0.4 mg/day)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Acetyldigoxin (0.4 mg/day) + Hydergin (3 mg/day)
Number of subjects: 80
Study: 31238507

Group type: EXPERIMENTAL
Intervention: 60-g faecal microbiota transplantation (FMT)
Number of subjects: 10
Study: 30982023

Group type: EXPERIMENTAL
Intervention: Food-specific IgG4
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Total IgE
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Specific IgE
Number of subjects: 46
Study: 27986738

Group type: EXPERIMENTAL
Intervention: Tailored health messages (THM)
Number of subjects: 357

Group type: EXPERIMENTAL
Intervention: Feedback to oncologists about the patients' trial THM
Number of subjects: 357

Group type: COMPARATOR
Intervention: No feedback to oncologists about the patients' trial THM
Number of subjects: 357
Study: 24718886

Group type: EXPERIMENTAL
Intervention: Panitumumab 6.0 mg/kg every 2 weeks + FOLFOX4
Number of subjects: 1183

Group type: COMPARATOR
Intervention: FOLFOX4
Number of subjects: 1183
Study: 22431413

Group type: EXPERIMENTAL
Intervention: Zoledronic acid
Number of subjects: 9355
Study: 19436060

Group type: EXPERIMENTAL
Intervention: Breastfeeding clinic intervention within 1 week postpartum
Number of subjects: 522

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 522

Group type: EXPERIMENTAL
Intervention: Breastfeeding clinic intervention
Number of subjects: 522
Study: 17264105

Group type: EXPERIMENTAL
Intervention: Strength and functional exercises
Number of subjects: 32

Group type: COMPARATOR
Intervention: Strength training
Number of subjects: 32
Study: 15339468

Group type: EXPERIMENTAL
Intervention: Sansheng Huatan Decoction combined with chemotherapy
Number of subjects: 160

Group type: COMPARATOR
Intervention: Chemotherapy only (Control)
Number of subjects: 160
Study: 12700441

Group type: EXPERIMENTAL
Intervention: sultamicillin (2 x 375 mg orally)
Number of subjects: 108

Group type: COMPARATOR
Intervention: amoxicillin (3 x 500 mg orally)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: sultamicillin
Number of subjects: 108

Group type: COMPARATOR
Intervention: amoxicillin
Number of subjects: 108
Study: 9627822

Group type: EXPERIMENTAL
Intervention: Anxiety management training (AMT)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Implosive therapy (IT)
Number of subjects: 6
Study: 8088611

Group type: EXPERIMENTAL
Intervention: Intraperitoneal chemotherapy (ip): cisplatin 200 mg/m2 plus etoposide 350 mg/m2 every 4 weeks for six cycles.
Number of subjects: 62

Group type: COMPARATOR
Intervention: Intravenous chemotherapy (iv): cisplatin 100 mg/m2 plus cyclophosphamide 600 mg/m2 every 3 weeks for six cycles.
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Intraperitoneal chemotherapy (ip)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Intravenous chemotherapy (iv)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Both regimens
Number of subjects: 62
Study: 2779810

Group type: EXPERIMENTAL
Intervention: Morphine 1 mg/h
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Buprenorphine 0.03 mg/h
Number of subjects: 20
Study: 1108581

Group type: EXPERIMENTAL
Intervention: 1.3 mg/kg of 0.5% plain bupivacaine
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: 2.6 mg/kg of 1.0% plain etidocaine
Number of subjects: 11

Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 11
Study: 31207663

Group type: COMPARATOR
Intervention: Red meat (control group)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Soy bean
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Non-soy legume
Number of subjects: 75
Study: 31094246

Group type: EXPERIMENTAL
Intervention: Loaded Plyometric Jump Training (LPJT)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Unloaded Plyometric Jump Training (UPJT)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Between-group analysis favoring LPJT
Number of subjects: 29
Study: 31373837

Group type: EXPERIMENTAL
Intervention: OTX-101 0.09%
Number of subjects: 1048

Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 1048
Study: 27848196

Group type: EXPERIMENTAL
Intervention: LT4 oral liquid formulation (SOL)
Number of subjects: 47

Group type: COMPARATOR
Intervention: LT4 tablet formulation (TAB)
Number of subjects: 47

Group type: COMPARATOR
Intervention: LT4 formulations (TAB and SOL)
Number of subjects: 47
Study: 26143310

Group type: EXPERIMENTAL
Intervention: Pentax Airway Scope AWS‐S200 video laryngoscope (AWS)
Number of subjects: 54
Study: 23313701

Group type: EXPERIMENTAL
Intervention: 80mg caffeine
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: 1000mg taurine
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Caffeine and taurine combined
Number of subjects: 19

Group type: COMPARATOR
Intervention: Matched placebo
Number of subjects: 19
Study: 21525259

Group type: EXPERIMENTAL
Intervention: DASH diet
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control diet
Number of subjects: 31
Study: 19563093

Group type: EXPERIMENTAL
Intervention: Tara KLamp (TK) method
Number of subjects: 166

Group type: COMPARATOR
Intervention: Forceps-guided (FG) method
Number of subjects: 166